STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS
El-Nenaey, W., Nafea, D., Imbaby, S., Abdel-latif Abd l-Magid, A. (2023). STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS. EKB Journal Management System, 5(4), 48-49. doi: 10.21608/alexpo.2023.256592.1747
Wafaa Ahmed El-Nenaey; Dalia Ahmed Nafea; Salma Alaa-Eldin Imbaby; Amany Samy Abdel-latif Abd l-Magid. "STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS". EKB Journal Management System, 5, 4, 2023, 48-49. doi: 10.21608/alexpo.2023.256592.1747
El-Nenaey, W., Nafea, D., Imbaby, S., Abdel-latif Abd l-Magid, A. (2023). 'STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS', EKB Journal Management System, 5(4), pp. 48-49. doi: 10.21608/alexpo.2023.256592.1747
El-Nenaey, W., Nafea, D., Imbaby, S., Abdel-latif Abd l-Magid, A. STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS. EKB Journal Management System, 2023; 5(4): 48-49. doi: 10.21608/alexpo.2023.256592.1747

STUDY THE FREQUENCY OF HUMAN PLATELET ANTIGEN-1 IN EGYPTIAN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGIC DISORDERS

ALEXMED ePosters
Article 1, Volume 5, Issue 4, December 2023, Page 48-49  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.256592.1747
View on SCiNiTO View on SCiNiTO
Authors
Wafaa Ahmed El-Nenaey1; Dalia Ahmed Nafea2; Salma Alaa-Eldin Imbaby3; Amany Samy Abdel-latif Abd l-Magid email 4
1Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University
2Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University
3Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Alexandria university, Egypt.
4Department of Clinical and Chemical Pathology, Faculty of medicine, Alexandria university
Abstract
INTRODUCTION
Platelets are active cells, which assist in hemostasis and blood coagulation. Their glycocalyx contains glycoproteins (GP) molecules through which platelet bind to other cells to perform their functions. The GPs (GPIa, GPIb, GPIIb and GPIIIa,) are produced by substitutions of single amino acid. Human platelet antigens (HPAs) are polymorphic amino acid sequences found on these GPs
GPIIIa is considered the most polymorphic glycoprotein and bears HPA-1, HPA-4, and HPA-6. HPA-1 is defined as the most important antigenic system. HPA-1a or HPA-1b antigens are due to the existence of leucine or proline at position 33 of the GPIIIa where the “a” represents the common allele and the “b” represents the rare allele.
HPA are associated with alloimmunization as they are the targets for platelet antibodies that lead to platelet destruction in post-transfusion refractoriness (PTR) and purpura (PTP) after platelet transfusion. Patients who are treated for hematological diseases associated with thrombocytopenia are highly vulnerable to platelet refractoriness when treated by prophylactic concentrated platelet transfusions to prevent bleeding. Consequently, accurate donor compatibility for platelet transfusions is very essential.
Keywords
HUMAN PLATELET ANTIGEN-1; THROMBOCYTOPENIA; HEMATOLOGIC DISORDERS INCOMPATIBILITY
Supplementary Files
Statistics
Article View: 78